Symbolbild · KI-generiert
Izotropic Corporation
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Izotropic Corporation is a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnosis, and treatment of breast cancers.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Izotropic Corporation | IZO | CSE | 12 Mio. USD |
| Nanalysis Scientific Corp. | NSCI | TSXV | 12 Mio. USD |
| Pharmala Biotech Holdings Inc. | MDMA | CSE | 12 Mio. USD |
| MedX Health Corp. | MDX | TSXV | 13 Mio. USD |
| Principal Technologies Inc. | PTEC | TSXV | 13 Mio. USD |
| KDA Group Inc. | KDA | TSXV | 12 Mio. USD |
| VVT Med Inc. | VVTM | TSXV | 11 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.